Metropolis Healthcare : ESOP/ESPS/SBEB Scheme

Ref: MHL/Sec&Legal/2022-23/63	Date: October 13, 2022
To,	To,
Head, Listing Compliance Department	Head, Listing Compliance Department,
BSE Limited,	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Plot No. C/1. G Block,
Dalal Street, Mumbai - 400 001.	Bandra - Kurla Complex, Bandra (East),
Scrip Code: 542650	Mumbai - 400051
	Scrip Symbol: METROPOLIS

Sub: Intimation of allotment of Equity shares under the Metropolis Healthcare Limited -Restrictive Stock Unit Plan, 2020

Ref: Pursuant to Regulation 30 and Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/ Madam,

This is to inform you that, with reference to the above mentioned subject, the Nomination and Remuneration Committee of the Board of the Directors of the Company, via circular resolution on October 13, 2022 inter alia:

• Approved the allotment of 6,043 (Six Thousand and Forty Three Only) Equity shares of Rs.2/- (Rupees Two Only) each at an exercise price of Rs. 2/- (Rupees Two Only) each aggregating to Rs. 12,086 (Twelve Thousand and Eighty Six Only) against the Restrictive Stock Units ("RSU") vested in and exercised by the employees of the Company under the MHL- Restrictive Stock Unit Plan, 2020.

Further, the said shares shall rank pari passu in all respects with the existing Equity shares of the Company.

In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in 'Annexure-I';

You are requested to kindly take the same on record.

Thanking you,

Yours faithfully

For Metropolis Healthcare Limited

Simmi Singh Bisht

Head - Legal and Secretarial

Membership No. A23360

BLOOD TESTS • DIAGNOSTICS • WELLNESS

Metropolis Healthcare Limited

Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.

CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: [e-mail]

Website: www.metropolisindia.com

Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.

'Annexure - I'

Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021:

Company Name and address of Registered Office	Metropolis Healthcare Limited
	Add: 250 D Udyog Bhavan Worli Mumbai -
	400030, Maharashtra, India
Name of the Stock Exchanges on which the	 BSE Limited ("BSE")
Company's shares are listed	 The National Stock Exchange of India Limited
	("NSE")
Filing date of the statement referred in regulation	May 23, 2021
10(b) of the SEBI (Share Based Employee
Benefits) Regulations, 2014 read with the SEBI
(Share Based Employee Benefits and Sweat
Equity) Regulations, 2021 with the recognized
Stock Exchange
Filing Number, if any	Application No:
	BSE - Case No.130335
	NSE - Application No.27089
	In-Principle Approval Letter:
	BSE: DCS/FL/PB/ESOP-IP/1301/2021-22 dated
	June 24, 2021
	NSE: NSE/LIST/27089 dated June 15, 2021
Title of the Scheme pursuant to which shares are	Metropolis-Restrictive Stock Unit Plan, 2020
issued, if any
Kind of security to be listed	Equity Shares
Par value of the shares	Re. 2/- per share
Date of issue of shares	October 13, 2022
Number of shares issued	6,043
Share Certificate No., if applicable	Not Applicable
Distinctive number of the share, if applicable	5,12,00,250 to 5,12,06,292 (both inclusive)
ISIN Number of the shares if issued in Demat	INE112L01020
Exercise price per share	Rs. 2/- per share
Premium per share	Nil
Total Issued shares after this issue	5,12,06,292 shares
Total Issued share capital after this issue	Rs.10,24,12,584
Details of any lock-in on the shares	50% of the Equity Shares allotted to each RSU
	holder, upon exercise of RSUs under MHL-RSU
	Plan, 2020 shall be subject to Lock-In for a period
	of 1 year from the date of the allotment;

BLOOD TESTS • DIAGNOSTICS • WELLNESS

Metropolis Healthcare Limited

Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.

CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: [e-mail]

Website: www.metropolisindia.com

Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.

Date of expiry of lock-in	October 13, 2023
Whether shares identical in all respects to existing	All equity shares rank pari passu in all respects
shares if not, when will they become identical?	with the existing Equity shares of the Company.
Details of listing fees, if payable	Not applicable

Relevant disclosures as per SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015:

	Options Vested	59,499
	Time within which option may be exercised	Within a maximum period of 5 years from the date
		of vesting of such options.
	Options exercised	6,043
	Money realized by exercise of options	Rs. 12,086/-
	The total number of shares arising as result of	6,043 Equity Shares
	exercise of option
	Options lapsed	1,11,765
	Diluted earnings per share pursuant to issue of	Rs. 5.52/- per shares
	equity shares on exercise of options
	Whether the scheme is in terms of SEBI (Share	Yes
	Based Employee Benefits and Sweat Equity)
	Regulations, 2021
For Metropolis Healthcare Limited

Simmi Singh Bisht

Head - Lead & Secretarial

Membership No. A23360

BLOOD TESTS • DIAGNOSTICS • WELLNESS

Metropolis Healthcare Limited

Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.

CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: [e-mail]

Website: www.metropolisindia.com

Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.